Ono Pharmaceutical describes new DGK-α and DGK-ζ inhibitors for cancer
April 4, 2024
Ono Pharmaceutical Co Ltd. has identified diacylglycerol kinase α (DGK-α, DGKA) and/or diacylglycerol kinase ζ (DGK-ζ, DGKZ) inhibitors reported to be useful for the treatment of cancer.
